NovaScan Fully Subscribes and Completes $3MM Financing
January 22nd, 2021 by NovaScanNovaScan, an emerging oncology company based in Chicago and Milwaukee, has announced that it has completed a $3MM financing.
...NovaScan Study on Cancer Recurrence and the Cole Frequency Published in a Peer-Reviewed Journal
November 1st, 2020 by NovaScanNo...
NovaScan is Awarded Two More Patents, Further Protecting Company Innovations
September 5th, 2020 by NovaScanNovaScan, a clinical stage oncology company based in Chicago and Milwaukee, was recently awarded patents for electrical scanning across tiss...
NovaScan welcomes Dr Charles Link to lead efforts in targeted drug delivery and to the NovaScan Board of Directors
January 15th, 2020 by NovaScanNovaScan, an emerging clinical stage oncology company, is pleased to announce that Charles ‘Chuck’ Link MD, FACS has joined the Board of...
NovaScan Wins First Prize and Third Place in two International Competitions
November 15th, 2019 by NovaScanNovember 15, 2019 NovaScan, an oncology company based in Chicago and Milwaukee, was awarded first prize in the BioPharma category in the I...
NovaScan Presented at American Society of Breast Surgeons Annual Meeting
July 10th, 2018 by NovaScanNovaScan recently presented in a poster session at the 2018 Annual Meeting of the American Society of Breast Surgeons, where the company pre...
NovaScan Clincal Results Published in top Dermatology Journal
May 19th, 2018 by NovaScanNovaScan’s clinical results in Mohs surgery were published in the highly regarded Journal of the American Academy of Dermatology. The arti...
NovaScan in the Press
January 2nd, 2018 by NovaScanNovaScan was recently featured in the Milwaukee Journal Sentinel, describing our recent progress in commercializing our MarginScan device fo...